Apollo Hospitals Q3 FY26: Revenue ₹6,477 Cr (vs ₹5,527 Cr in Q3 FY25), PAT ₹502 Cr (vs ₹372 Cr in Q3 FY25)
In Q3 FY26 (three months ended 31/12/2025) Apollo Hospitals delivered consolidated revenue of ₹6,477 Cr and reported consolidated PAT of ₹502 Cr. Consolidated EBITDA was ₹965 Cr, reflecting operating leverage across hospital, retail/diagnostics and HealthCo businesses. The Board approved an interim dividend of ₹10 per share and the Group launched a 250‑bed quaternary facility in Pune as part of capacity expansion. Management highlighted growth in international patient services and sustained transplant volumes as drivers for near‑term demand.
Consolidated Revenue (Q3 FY26)
₹6,477 CrConsolidated EBITDA (Q3 FY26)
₹965 CrConsolidated PAT (Q3 FY26)
₹502 CrDiluted EPS (Q3 FY26, not annualised)
₹34.94 per sharevs ₹25.89 per share in Q3 FY25
